Description

18,962,247 equity shares of Artemis Medicare Services Limited listed on BSE with effect from December 24, 2025, issued on preferential basis pursuant to conversion of Compulsory Convertible Debentures.

Summary

BSE has approved the listing of 18,962,247 equity shares of Artemis Medicare Services Limited (Scrip Code: 542919) with effect from December 24, 2025. These shares were issued to non-promoters on a preferential basis pursuant to the conversion of Compulsory Convertible Debentures (CCDs) at an issue price of Rs. 174.03 per share.

Key Points

  • 18,962,247 equity shares of Re. 1/- each listed on BSE
  • Shares issued at premium of Rs. 173.03 per share (total issue price: Rs. 174.03)
  • Issued to non-promoters on preferential basis
  • Issued pursuant to conversion of Compulsory Convertible Debentures (CCDs)
  • New shares rank pari-passu with existing equity shares
  • Scrip Code: 542919
  • ISIN: INE025R01021
  • Distinctive Numbers: 139238251 to 158200497

Regulatory Changes

No regulatory changes introduced by this circular.

Compliance Requirements

  • Trading members are informed to note the listing of new securities
  • New shares are permitted for trading from December 24, 2025
  • Securities to be traded under existing scrip code 542919

Important Dates

  • Notice Date: December 23, 2025
  • Allotment Date: November 15, 2025
  • Listing and Trading Commencement: December 24, 2025

Impact Assessment

Market Impact: The listing represents a significant equity dilution through conversion of CCDs, adding approximately 18.96 million shares to the tradable float. The conversion was executed at Rs. 174.03 per share, indicating the valuation at which non-promoter investors participated.

Shareholding Impact: As these shares were allotted to non-promoters on a preferential basis, there will be dilution in existing shareholding percentages. The pari-passu ranking ensures equal rights with existing equity holders.

Trading Impact: Increased float may impact liquidity and price discovery for the scrip. Market participants should account for the expanded equity base when analyzing the company’s market capitalization and per-share metrics.

Impact Justification

Material equity dilution of 18.96 million shares from CCD conversion affecting non-promoter shareholding structure, but routine listing notification with limited market-wide impact